A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

January 19, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Acute Respiratory Viral Infection
Interventions
OTHER

No Intervention

This is an observational study to assess the incidence and key disease characteristics of symptomatic acute respiratory viral infections in a high-risk population at risk for poor outcomes. Duration of each participant will be up to 12 months.

Trial Locations (4)

48202

Henry Ford Hospital, Detroit

94305

Stanford Hospital and Clinics, Palo Alto

98109

Fred Hutchinson Research Center, Seattle

L8L8E7

Hamilton Health Sciences, Hamilton

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY